J 2010

Importance of screening of IgG anti-IgA antibodies in hypogammaglobulinemic subjects to prevent anaphylactoid reactions

THON, Vojtěch

Basic information

Original name

Importance of screening of IgG anti-IgA antibodies in hypogammaglobulinemic subjects to prevent anaphylactoid reactions

Name in Czech

Význam vyšetření IgG anti-IgA protilátek k prevenci anafylaktoidní reakce u hypogamaglobulinémií

Authors

THON, Vojtěch (203 Czech Republic, guarantor, belonging to the institution)

Edition

Klinická imunológia a alergológia, 2010, 1335-0013

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

Slovakia

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/10:00058965

Organization unit

Faculty of Medicine

Keywords (in Czech)

anti-IgA protilátky; anafylaktoidní reakce; hypogamaglobulinémie

Keywords in English

anti-IgA antibodies; anaphylactoid reaction; hypogammaglobulinemia

Tags

International impact, Reviewed
Změněno: 21/4/2013 11:29, Ing. Mgr. Věra Pospíšilíková

Abstract

V originále

Anti-IgA antibodies can cause severe anaphylactoid reactions in the case of blood transfusion or substitution immunoglobulin therapy in patients with hypogammaglobulinemia. We found a significant amount of anti-IgA antibodies in 10 % of patients with the most common primary hypogammaglobulinemia (selective IgA deficiency and common variable immunodeficiencies) where the serum IgA level was lower than 0.05 g/L. Knowledge of the presence of antibodies against IgA is important in clinical practice in order to prevent an anaphylactic reaction during blood transfusion or during immunoglobulin substitution therapy.

In Czech

Vyšetření přítomnosti anti-IgA protilátlek je důležité pro prevenci anafylaktoidní reakce v případě podání krevních transfúzí nebo substituční léčby imunoglobulinovými preparáty.

Links

7E08062, research and development project
Name: Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes
Investor: Ministry of Education, Youth and Sports of the CR, Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes